Drug
Sparc0912
Sparc0912: highest development phase Phase 3, developed by Sun Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sun Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| SPARC0912 NCT00947661 | Phase 3 | Open Angle Glaucoma |
Latest
No recent events.
Follow Sparc0912 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.